Liminatus Pharma Warrants
LIMNW
22 hedge funds and large institutions have $90.1K invested in Liminatus Pharma Warrants in 2026 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
24% more capital invested
Capital invested by funds: $72.6K → $90.1K (+$17.5K)
5% more funds holding
Funds holding: 21 → 22 (+1)
0.19% less ownership
Funds ownership: 20.53% → 20.34% (-0.19%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.21K |
| 2 |
VF
Virtu Financial
New York
|
+$744 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$1.75K |
| 2 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$1.21K |
| 3 |
GS
GTS Securities
Miami,
Florida
|
-$7 |
| 4 |
CS
Clear Street
New York
|
-$4 |
LIMNW Hedge Fund Activity: Q2 2026 in Review
22 of the 8,320 institutional investors tracked by Wall St. Rank reported a position in Liminatus Pharma Warrants (LIMNW) for Q2 2026, worth a combined $90.1K — up 24% from $72.6K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new LIMNW positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 3 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $1.21K. The largest seller was Wolverine Asset Management, cutting an estimated $1.75K.
- 22 institutional investors held Liminatus Pharma Warrants (LIMNW) as of Q2 2026, up from 21 in Q1 2026.
- Funds reported $90.1K of Liminatus Pharma Warrants stock for Q2 2026, up 24% quarter-over-quarter.
- 2 funds opened new Liminatus Pharma Warrants positions in Q2 2026 and 1 closed out, a net change of +1 holder.
- The largest Liminatus Pharma Warrants buyer in Q2 2026 was Susquehanna International Group, an estimated $1.21K added.
- The largest Liminatus Pharma Warrants seller in Q2 2026 was Wolverine Asset Management, an estimated $1.75K sold.
Based on aggregated 13F filings for Q2 2026.